Market Cap | 46.44M | P/E | 20.75 | EPS this Y | 114.00% | Ern Qtrly Grth | 196.80% |
Income | -9.3M | Forward P/E | 37.35 | EPS next Y | -18.80% | 50D Avg Chg | -3.00% |
Sales | 31.64M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 21.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -31.00% |
Recommedations | 2.00 | Quick Ratio | 0.43 | Shares Outstanding | 8.06M | 52W Low Chg | 108.00% |
Insider Own | 47.47% | ROA | -0.25% | Shares Float | 3.83M | Beta | 0.53 |
Inst Own | 11.12% | ROE | - | Shares Shorted/Prior | 4.34K/8.69K | Price | 5.60 |
Gross Margin | 61.59% | Profit Margin | -29.38% | Avg. Volume | 11,100 | Target Price | 11.00 |
Oper. Margin | 21.09% | Earnings Date | Oct 10 | Volume | 10,203 | Change | -0.13% |
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Maxim Group | Buy | Aug 29, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
PORTNOY DAVID | Chairman, Co-CEO Chairman, Co-CEO | Nov 17 | Buy | 4.89 | 1,050 | 5,134 | 230,621 | 11/21/22 |
Berger Harold D. | Director Director | Jul 07 | Option | 2.13 | 22,500 | 47,925 | 50,401 | 09/01/22 |
Mikulinsky Oleg | Chief Information Of.. Chief Information Officer | Aug 25 | Option | 3.20 | 20,000 | 64,000 | 84,349 | 08/29/22 |
PORTNOY DAVID | Chairman, Co-CEO Chairman, Co-CEO | Aug 25 | Option | 3.14 | 70,270 | 220,648 | 860,742 | 08/29/22 |
Portnoy Mark L. | Co-CEO Co-CEO | Aug 25 | Option | 3.14 | 59,459 | 186,701 | 821,973 | 08/29/22 |
PORTNOY DAVID | Chairman, Co-CEO Chairman, Co-CEO | Jan 15 | Buy | 7.84 | 15,500 | 121,520 | 494,772 | 01/15/21 |
PORTNOY DAVID | Chairman, Co-CEO Chairman, Co-CEO | Nov 10 | Buy | 7.04 | 3,436 | 24,189 | 472,531 | 11/10/20 |
PORTNOY DAVID | Chairman, Co-CEO Chairman, Co-CEO | Nov 05 | Buy | 6.67 | 9,940 | 66,300 | 15,061 | 11/05/20 |
PORTNOY DAVID | Chairman, Co-CEO Chairman, Co-CEO | Nov 02 | Buy | 6.9 | 17,750 | 122,475 | 461,341 | 11/02/20 |
PORTNOY DAVID | Chairman, Co-CEO Chairman, Co-CEO | Oct 26 | Buy | 7.78 | 9,897 | 76,999 | 445,491 | 10/26/20 |